AAV Vectors
Cross-source consensus on AAV Vectors from 1 sources and 4 claims.
1 sources · 4 claims
Uses
Comparisons
Evidence quality
Highlighted claims
- AAV vectors are generally chosen for gene therapy because they usually do not integrate into the recipient genome. — A rare case of gene therapy-linked cancer
- AAV vectors generally remain outside the recipient genome, unlike retroviral and lentiviral vectors. — A rare case of gene therapy-linked cancer
- AAV vectors are preferred in gene therapy development partly because they have a lower tendency to integrate. — A rare case of gene therapy-linked cancer
- AAV vectors are not broadly portrayed as unsafe based on this rare tumor case. — A rare case of gene therapy-linked cancer